Nicola Klein to Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
This is a "connection" page, showing publications Nicola Klein has written about Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18.
Connection Strength
0.431
-
Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy. Obstet Gynecol. 2017 09; 130(3):599-608.
Score: 0.148
-
Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination, Vaccine Safety Datalink, 2008-2011. Vaccine. 2016 Jan 02; 34(1):167-71.
Score: 0.130
-
An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015. Pediatr Infect Dis J. 2015 Sep; 34(9):983-91.
Score: 0.129
-
Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med. 2012 Feb; 271(2):193-203.
Score: 0.025